219 related articles for article (PubMed ID: 29599912)
1. Coagulation cascade and complement system in systemic lupus erythematosus.
Liang Y; Xie SB; Wu CH; Hu Y; Zhang Q; Li S; Fan YG; Leng RX; Pan HF; Xiong HB; Ye DQ
Oncotarget; 2018 Mar; 9(19):14862-14881. PubMed ID: 29599912
[TBL] [Abstract][Full Text] [Related]
2. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
Julkunen H; Ekblom-Kullberg S; Miettinen A
Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
[TBL] [Abstract][Full Text] [Related]
3. Multi-Platform Omics Analysis Reveals Molecular Signatures for Pathogenesis and Activity of Systemic Lupus Erythematosus.
Huang X; Luu LDW; Jia N; Zhu J; Fu J; Xiao F; Liu C; Li S; Shu G; Hou J; Kang M; Zhang D; Xu Y; Wang Y; Cui X; Lai J; Li J; Tai J
Front Immunol; 2022; 13():833699. PubMed ID: 35514958
[TBL] [Abstract][Full Text] [Related]
4. Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus.
Jüptner M; Flachsbart F; Caliebe A; Lieb W; Schreiber S; Zeuner R; Franke A; Schröder JO
Lupus; 2018 Apr; 27(4):600-609. PubMed ID: 29050534
[TBL] [Abstract][Full Text] [Related]
5. Differential expressions of plasma proteins in systemic lupus erythematosus patients identified by proteomic analysis.
Madda R; Lin SC; Sun WH; Huang SL
J Microbiol Immunol Infect; 2019 Oct; 52(5):816-826. PubMed ID: 30170966
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum interleukin-34 level in juvenile systemic lupus erythematosus and disease activity.
El-Banna HS; El Khouly RM; Gado SE
Clin Rheumatol; 2020 May; 39(5):1627-1632. PubMed ID: 31907692
[TBL] [Abstract][Full Text] [Related]
7. Differential diagnosis of systemic lupus erythematosus and rheumatoid arthritis with complements C3 and C4 and C-reactive protein.
Li W; Li H; Song W; Hu Y; Liu Y; DA R; Chen X; Li Y; Ling H; Zhong Z; Zhang F
Exp Ther Med; 2013 Nov; 6(5):1271-1276. PubMed ID: 24223657
[TBL] [Abstract][Full Text] [Related]
8. Value of combined detection of anti-nuclear antibody, anti-double-stranded DNA antibody and C3, C4 complements in the clinical diagnosis of systemic lupus erythematosus.
Qu C; Zhang J; Zhang X; Du J; Su B; Li H
Exp Ther Med; 2019 Feb; 17(2):1390-1394. PubMed ID: 30680018
[TBL] [Abstract][Full Text] [Related]
9. Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL).
Savelli SL; Roubey RAS; Kitzmiller KJ; Zhou D; Nagaraja HN; Mulvihill E; Barbar-Smiley F; Ardoin SP; Wu YL; Yu CY
Front Immunol; 2019; 10():885. PubMed ID: 31134052
[TBL] [Abstract][Full Text] [Related]
10. Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity.
Kim AHJ; Strand V; Sen DP; Fu Q; Mathis NL; Schmidt MJ; Bruchas RR; Staten NR; Olson PK; Stiening CM; Atkinson JP
Arthritis Rheumatol; 2019 Mar; 71(3):420-430. PubMed ID: 30294950
[TBL] [Abstract][Full Text] [Related]
11. Serum complements and immunoglobulin profiles in systemic lupus erythematosus patients: An observational study at a teaching hospital.
Rana RS; Naik B; Yadav M; Singh U; Singh A; Singh S
J Family Med Prim Care; 2022 Feb; 11(2):608-613. PubMed ID: 35360789
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus.
Kao AH; Navratil JS; Ruffing MJ; Liu CC; Hawkins D; McKinnon KM; Danchenko N; Ahearn JM; Manzi S
Arthritis Rheum; 2010 Mar; 62(3):837-44. PubMed ID: 20187154
[TBL] [Abstract][Full Text] [Related]
13. Elevated Layilin-Positive Monocyte Levels in the Peripheral Blood of Patients with Systemic Lupus Erythematosus Reflect Their Autoimmune Status.
Liu C; Wang Y; Zhang YH; Yuan Z; Zhang Z; Zeng X; Guan Z; Bahabayi A; Lu S
Immunol Invest; 2023 Nov; 52(7):879-896. PubMed ID: 37642473
[TBL] [Abstract][Full Text] [Related]
14. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.
Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF
Front Immunol; 2020; 11():1047. PubMed ID: 32625200
[TBL] [Abstract][Full Text] [Related]
15. A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus.
Ho A; Barr SG; Magder LS; Petri M
Arthritis Rheum; 2001 Oct; 44(10):2350-7. PubMed ID: 11665976
[TBL] [Abstract][Full Text] [Related]
16. Revisiting the complement system in systemic lupus erythematosus.
Sharma M; Vignesh P; Tiewsoh K; Rawat A
Expert Rev Clin Immunol; 2020 Apr; 16(4):397-408. PubMed ID: 32228236
[No Abstract] [Full Text] [Related]
17. Decreased low-density lipoprotein and the presence of pulmonary arterial hypertension among newly diagnosed drug-naïve patients with systemic lupus erythematosus: D-dimer as a mediator.
Huang J; An Q; Zhang CL; He L; Wang L
Exp Ther Med; 2022 Sep; 24(3):595. PubMed ID: 35949327
[TBL] [Abstract][Full Text] [Related]
18. Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus.
Magro-Checa C; Schaarenburg RA; Beaart HJ; Huizinga TW; Steup-Beekman GM; Trouw LA
Lupus; 2016 Jul; 25(8):878-88. PubMed ID: 27252265
[TBL] [Abstract][Full Text] [Related]
19. Measurement of serum interferon alpha in Egyptian patients with systemic lupus erythematosus and evaluation of its effect on disease activity: a case-control study.
Fayed A; El Menyawi MM; Ghanema M; Shaker O; Elgohary R
Reumatismo; 2020 Nov; 72(3):145-153. PubMed ID: 33213127
[TBL] [Abstract][Full Text] [Related]
20. Changes of Serum IL-6, IL-17, and Complements in Systemic Lupus Erythematosus Patients.
Tang Y; Tao H; Gong Y; Chen F; Li C; Yang X
J Interferon Cytokine Res; 2019 Jul; 39(7):410-415. PubMed ID: 31173544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
